le Roux, Carel W.
Ottosson, Johan
Näslund, Erik
Cohen, Ricardo V. https://orcid.org/0000-0001-8779-3055
Stenberg, Erik
Sundbom, Magnus
Näslund, Ingmar
Article History
Received: 6 July 2020
Revised: 13 August 2020
Accepted: 14 August 2020
First Online: 26 August 2020
Compliance with Ethical Standards
:
: The following conflicts of interest were declared:CW le Roux: advisory boards and lecture fees for Novo Nordisk, Sanofi, Boehringer Ingelheim, Johnson & Johnson, Herbalife, Keyron, and GI DynamicsJ Ottosson: advisory boards for Johnson & Johnson and Vifor PharmaE Näslund: NoneRV Cohen: advisory boards and lecture fees for Johnson & Johnson, Keyron, GI Dynamics, and Medtronic; research grant from Johnson & Johnson and MedtronicE Stenberg: NoneM Sundbom: NoneI Näslund: advisory boards and lecture fees for Baricol Bariatrics AB, Johnson & Johnson, and AstraZeneca
: This article does not contain any studies with human participants or animals performed by any of the authors.